GENFIT Pipeline Days - 5 et 19 octobre 2022 – Paris, NYC.
Genfit à la rencontre des investisseurs - Genfit to meet with investors
GENFIT Pipeline Days – 5 et 19 octobre 2022 – Paris, NYC (sous-titres français)
Introduction – Pascal Prigent, Directeur Général
Acute-on chronic liver failure (ACLF)
Disease State – Jonel Trebicka, MD, PhD – Professeur de médecine et chef du service de médecine interne, UKM Uniklinikum Muenster, Allemagne
Disease State – Jennifer C. Lai, MD, MBA – Hépatologue spécialisée dans la transplantation, University of California, UCSF, États-Unis
GENFIT’s Program VS-01-ACLF – Vincent Forster, PhD; Prof. Katharina Staufer, MD
GENFIT’s Program NTZ – Dean Hum, PhD; Carol Addy, MD
Market Opportunity – Back Bay Life Science – Stephen Gauldie, PhD; Mavra Nasir, PhD
Hepatic Encephalopathy (HE)
Disease State – Jonel Trebicka, MD, PhD – Professeur de médecine et chef du service de médecine interne, UKM Uniklinikum Muenster, Allemagne
Disease State – Jennifer C. Lai, MD, MBA – Hépatologue spécialisée dans la transplantation, University of California, UCSF, États-Unis
GENFIT’s Program VS-02-HE – Vincent Forster, PhD; Meriam Kabbaj, PhD
Market Opportunity – Pascal Caisey
Cholangiocarcinoma (CCA)
Disease State – Mark Yarchoan, MD – Professeur associé d’oncologie, John Hopkins Medicine, Baltimore, États-Unis
Disease State – Angela Lamarca, MD – Oncologie Médicale, Fundacion Jimenez Diaz University Hospital, Madrid, Espagne
GENFIT’s Program GNS561 – Dean Hum, PhD; Carol Addy, MD
Market Opportunity – Pascal Caisey
Urea cycle disorder (UCD) & organic acidemia disorder (OAD)
Disease State – Vincent Forster, PhD
GENFIT’s Program VS-01 – Vincent Forster, PhD
Market Opportunity – Pascal Caisey
Conclusion & messages clés
GENFIT Pipeline Days – October 5th & 19th, 2022 – Paris, NYC (English subtitles)
Introduction – Pascal Prigent, CEO
Acute-on chronic liver failure (ACLF)
Disease State – Jonel Trebicka, MD, PhD, Professor of Medicine, Chair of Department of Internal Medicine, UKM Uniklinikum Muenster, Germany
Disease State – Jennifer C. Lai, MD, MBA – Transplant Hepatologist, University of California, UCSF, USA
GENFIT’s Program VS-01-ACLF – Vincent Forster, PhD; Prof. Katharina Staufer, MD
GENFIT’s Program NTZ – Dean Hum, PhD; Carol Addy, MD
Market Opportunity – Back Bay Life Science – Stephen Gauldie, PhD; Mavra Nasir, PhD
Hepatic Encephalopathy (HE)
Disease State – Jonel Trebicka, MD, PhD, Professor of Medicine, Chair of Department of Internal Medicine, UKM Uniklinikum Muenster, Germany
Disease State – Jennifer C. Lai, MD, MBA – Transplant Hepatologist, University of California, UCSF, USA
GENFIT’s Program VS-02-HE – Vincent Forster, PhD; Meriam Kabbaj, PhD
Market Opportunity – Pascal Caisey
Cholangiocarcinoma (CCA)
Disease State – Mark Yarchoan, MD, Associate Professor of Oncology at John Hopkins Medicine, Baltimore, USA
Disease State – Angela Lamarca, MD – Medical Oncology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
GENFIT’s Program GNS561 – Dean Hum, PhD; Carol Addy, MD
Market Opportunity – Pascal Caisey
Urea cycle disorder (UCD) & organic acidemia disorder (OAD)
Disease State – Vincent Forster, PhD
GENFIT’s Program VS-01 – Vincent Forster, PhD
Market Opportunity – Pascal Caisey
Closing remarks & Take-home messages
Les vidéos Genfit déjà diffusées sur ce site sont visibles ici : Vidéos Genfit